Skip to main content
SpringerLink
Log in

Role of the endogenous cannabinoid system as a modulator of dopamine transmission: Implications for Parkinson’s disease and schizophrenia

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

The endogenous cannabinoid system is a new signaling system composed by the central (CB1) and the peripheral (CB2) receptors, and several lipid transmitters including anandamide and 2-arachidonylg-lycerol. This system is the target of natural cannabinoids, the psychoactive constituents ofCannabis sativa preparations (marijuana, hashish). Acute and chronic cannabis exposure has been associated with subjective feelings of pleasure and relaxation, but also to the onset of psychiatric syndromes, a decrease of the efficacy of neuroleptics and alterations in the extrapyramidal system regulation of motor activity. These actions points to a tight association of the cannabinoid system with the brain dopaminergic circuits involved in addiction, the clinical manifestation of positive symptoms of schizophrenia and Parkinson’s disease. The present work discuss anatomical, biochemical and pharmacological evidences supporting a role for the endogenous cannabinoid system in the modulation of dopaminergic transmission. Cannabinoid CB1 receptors are present in dopamine projecting brain areas. In primates and certain rat strains it is also located in dopamine cells of the A8, A9 and A10 mesencephalic cell groups, as well as in hypothalamic dopaminergic neurons controlling prolactin secretion. CB1 receptors co-localize with dopamine D1/D2 receptors in dopamine projecting fields. Manipulation of dopaminergic transmission is able of altere the synthesis and release of anandamide as well as the expression of CB1 receptors. Additionally, CB1receptors can switch its transduction mechanism to oppose to the ongoing dopamine signaling. Acute blockade of CB1 receptor potentiates the facilitatory role of dopamine D2 receptor agonists on movement. CB1 stimulation results in sensitization to the motor effects of indirect dopaminergic agonists. The dynamics of these changes indicate that the cannabinoid system is an activity-dependent modulator of dopaminergic transmission, an hypothesis relevant for the design of new therapeutic strategies for dopamine-related diseases such as the psychosis and Parkinson’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson LA, Anderson JJ, Chase TN and Walters JR (1995) The cannabinoid agonist WIN 55, 212-2 and CP 55, 940 attenuate rotational behaviour induced by a dopamine Dl but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway.Brain Res.,691, 106–114.

    Article  PubMed  CAS  Google Scholar 

  • Andreasson S, Allebeck P, Engstrom A, Rydberg V (1987) Cannabis and Schizophrenia: a longitudinal study of Swedish conscripts.Lancet,ii, 1483–1486.

    Article  Google Scholar 

  • Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A and Piomelli D (1997) Functional role of high-affinity anandamide transport as revealed by selective inhibition.Science,277, 1094–1097.

    Article  PubMed  CAS  Google Scholar 

  • Cadogan AK, Alexander SPH, Boyd EA and Kendall DA (1997) Influence of cannabinoids on electrically evoked dopamine release and cAMP generation in the rat striatum.J. Neurochem.,69, 1131–1137.

    Article  PubMed  CAS  Google Scholar 

  • Chen J, Paredes W, Li J, Smith D, Lowinson J and Gardner EL (1990) Delta-9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis.PsychopharmacoL,102, 156–162.

    Article  CAS  Google Scholar 

  • Clifford DB (1983) Tetrahydrocannabinol for tremor in multiple sclerosis.Ann. Neurol.,13, 669–671.

    Article  PubMed  CAS  Google Scholar 

  • Devane WA, Dysarz FA III, Johnson MR, Melvin LS and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain.Mol. Pharmacol.,34, 605–613.

    PubMed  CAS  Google Scholar 

  • Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Nature,258, 1946–1949.

    CAS  Google Scholar 

  • Dewey WL (1986) Cannabinoid Pharmacology.Pharmacol. Rev.,38, 151–178.

    PubMed  CAS  Google Scholar 

  • French ED, Dillon K and Wu x (1997) Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra.NeuroReport,8, 649–652.

    Article  PubMed  CAS  Google Scholar 

  • Gaoni Y and Mechoulam R (1964) Isolation, structure and partial synthesis on an active constituent of hashish.J Am. Chem. Soc,86, 1646–1654.

    Article  CAS  Google Scholar 

  • Gardner EL, Paredes W, Smith D, Donner A, Milling C, Cohen D and Morrison D (1988) Facilitation of brain stimulation reward by 5 -tetrahydrocannabinol.Psychopharmacol,96, 142–144.

    Article  CAS  Google Scholar 

  • Gardner EL and Vorel, RH (1998) Cannabinoid transmission and reward-related events.Neurobiology of Disease.5, 502–533.

    Article  Google Scholar 

  • Gessa, GL, Melis, M, Muntoni AL, Diana M (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.Eur. j. Pharmacol. 341, 39–44.

    Article  PubMed  CAS  Google Scholar 

  • Giuffrida, A., Parsons, L.H., Kehrr, A., Rodriguez de Fonseca, F., Navarro, M., Piomelli, D. (1999) Dopamine activation of endogenous cannabinoid signalling in dorsal striatum.Nature Neuroscience 2, 358–363.

    Article  PubMed  CAS  Google Scholar 

  • Glass M, Brotchie JM and MAneuf YP (1997a) Modulation of neurotransmission by cannabinoids in the basal ganglia.Eur. J. Neurosci.,9, 199–203.

    Article  PubMed  CAS  Google Scholar 

  • Glass M and Felder C (1997b) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.J. Neurosci.,17, 5327–5333.

    PubMed  CAS  Google Scholar 

  • Gorriti, M.A., Rodriguez de Fonseca, F.A., Navarro, M., Palomo, M. (1999) Chronic treatment with (-)-delta-9-tet-rahydrocannabinol results in sensitization to the psychomotor effects of amphetamine.Eur. J. Pharmacol. 365, 133–142.

    Article  PubMed  CAS  Google Scholar 

  • Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.Neuroscience,41, 1–24.

    Article  PubMed  CAS  Google Scholar 

  • Gueudet C, Santucci V, Rinaldi-Carmona M, Soubrie P and Le Fur G (1995) The CBj cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.NeuroReport,6, 1293–1297.

    Article  Google Scholar 

  • Halikas JA, Weller RA, Mouse CL and Hoffman RA (1985) A longitudinal study of marijuana effects.Int. J. Addiction,20, 701–711.

    CAS  Google Scholar 

  • Hampson RE, Evans GJO, Mu J, Zhuang S, King VC, Childers SR and Deadwyler SA (1995) Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium “A-current” in cultured hippocampal neurons.Life Sri.,56, 2081–2087.

    Article  CAS  Google Scholar 

  • Herkenham M, Lynn AB, de Costa BR and Richfield EK (1991) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.Brain Res,547, 267–274.

    Article  PubMed  CAS  Google Scholar 

  • Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR and Rice (1990) Cannabinoid receptor localization in brain.Proc. Natl. Acad. Sci. USA.,87, 1932–1936.

    Article  PubMed  CAS  Google Scholar 

  • Howlett AC (1995) Pharmacology of cannabinoid receptors.Ann. Rev. Pharmacol. Toxicol. 35, 607–634.

    Article  CAS  Google Scholar 

  • Knudsen P and Vilmar P (1984) Cannabis and neuroleptics agents in schizophrenia.Acta Psychiatr. Scand.,69, 162–174.

    Article  PubMed  CAS  Google Scholar 

  • Landfield PW, Cadwallader LB and Vinsant S (1988) Quantitative changes in hippocampal structure following chronic exposure to A -tetrahydrocannabinol: possible mediation by glucocorticoid systems.Brain. Res.,443, 47–62.

    Article  PubMed  CAS  Google Scholar 

  • Le Moal M and Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles.Physiol. Rev.,71, 155–234.

    PubMed  Google Scholar 

  • Leweke, FM, Giuffrida, A, Wurster, U, Emrich, HM and Piomelli, D (1999) Elevated endogenous cannabinoids in schizophrenia.Neuro Report 10, 1665–1669.

    CAS  Google Scholar 

  • Mackie Kand Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.Proc. Natl. Acad. Sci. USA,89, 3825–3829.

    Article  PubMed  CAS  Google Scholar 

  • Mailleux P and Vanderhaeghen JJ (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautoagraphy and in situ hybridization histochemistry.Neuroscience,48, 655–688.

    Article  PubMed  CAS  Google Scholar 

  • Mailleux P and Vanderhaeghen JJ (1993) Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: An in situ hybridization study.J. Neurochem.,61, 1705–1712.

    Article  PubMed  CAS  Google Scholar 

  • Maneuf YP and Brotchie JM (1997) Paradoxical action of the cannabinod WIN 55, 212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices.Br. J. Pharmacol,120, 1397–1398.

    Article  PubMed  CAS  Google Scholar 

  • Maneuf YP, Crossman AR and Brotchie JM (1996) Modulation of GABAergic transmission in the globus pallidus by the synthetic canabinoid WIN 55, 212-2.Synapse,22, 383–385.

    Article  Google Scholar 

  • Maneuf YP, Crossman AR and Brotchie JM (1997) The cannabinoid receptor agonist WIN 55, 212-2 reduces D2, but not Dl, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson’s disease.Exp. Neurol,148, 265–270.

    Article  PubMed  CAS  Google Scholar 

  • Martin-Calderon JL, Muftoz RM, Villanua, del Arco I, Moren JL, Rodriguez de Fonseca F and Navarro M (1998) Characterization of the acute endocrine actions of HU-210, a potent synthetic cannabinoid in rats.Eur. J. Pharmacol. 344, 77–86.

    Article  PubMed  CAS  Google Scholar 

  • Matsuda LA, Bonner TI and Lolait SJ (1993) Localization of Cannabinoid Receptor mRNA in rat brain.J. Comp. Neurol,327, 535–550.

    Article  PubMed  CAS  Google Scholar 

  • Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI (1990) Structure of a brain cannabinoid receptor and functional expression of the cloned cDNA.Nature,346, 561–564.

    Article  PubMed  CAS  Google Scholar 

  • Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Comton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J and Vogel Z (1995) Identification of an endogenous 2-monoglyceride present in canine gut that binds to cannabinoid receptor.Biochem. Pharmacol,50, 83–90.

    Article  PubMed  CAS  Google Scholar 

  • Nagayama, T., Sinor, A.D., Simon, R.P., Cheen, J., Graham, S.H., Jin, K., Greenberg, D.A. (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures.J. Neurosci. 19, 2987–95.

    PubMed  CAS  Google Scholar 

  • Navarro, M, Cowen, J, Carrera, MRA, del Arco, I., Villanua, MA, Martin Y, Roberts, AJ, Koob, GF and Rodriguez de Fonseca, F (1998) CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.NeuroReport 9, 3397–3402.

    Article  PubMed  CAS  Google Scholar 

  • Navarro M, Fernandez-Ruiz JJ, de Miguel R, Hernandez ML, Cebeira M and Ramos JA (1993) Motor disturbances induced by an acute dose of delta-9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations.Pharmacol. Biochem. Behav.,45, 291–298.

    Article  PubMed  CAS  Google Scholar 

  • Navarro M, Hernandez E, Munoz RM, Del Arco I, Villanua MA, Carrera MRA and Rodriguez de Fonseca F (1997) Acute administration of the CBj receptor antagonist SR 141716A induces anxiety-like responses in the rat.NeuroReport,8, 491–496.

    Article  PubMed  CAS  Google Scholar 

  • Ng Cheong Ton JM, Gerhardt SA, Freidman M, Etgen A, Rose GM, Sharlegg NS and Gardner EL (1988) The effect of delta-9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study.Brain Res.,451, 59–68.

    Article  PubMed  CAS  Google Scholar 

  • Nunez-Dominguez LA and Gurpegui-Fernandez de Legaria M (1997) Cannabis psychosis: a five year follow-up study.International Meeting on Interactive Monoaminergic Brain Disorders. October 8-12, 1997, P3.5, pp 76.

  • Ong, W.Y. and Mackie, K. (1999) A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain.Neuroscience 92, 1177–1191.

    Article  PubMed  CAS  Google Scholar 

  • Pertwee RG and Greentree SG (1988) Delta-9-tetrahydrocan-nabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide.Neuropharmacol,27, 485–491.

    Article  CAS  Google Scholar 

  • Piazza PV and Le Moal M (1996b) Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids and dopaminergic neurons.Ann. Rev. Pharmacol. Toxicol,36, 359–378.

    Article  CAS  Google Scholar 

  • Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie, Breliere JC and Le Fur G (1994) SR 141716A a potent and selective antagonist of the brain cannabinoid receptor.FEBS Lett,350, 240–244.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez de Fonseca F, Carrera MRA, Navarro M, Koob GF and Weiss F (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.Science,276, 2050–2054.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez de Fonseca F, Fernandez-Ruiz JJ, Murphy LL, Cebeira M, Steger RW, Bartke A and Ramos A (1992) Acute effects of 5 -tetrahydrocannabinol on dopaminergic activity in several rat brain areas.Pharmacol. Biochem. Behav. 42, 269–275.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez de Fonseca F, Gorriti MA, Fernandez-Ruiz JJ, Pal-omo T and Ramos JA (1994a) Down regulation of rat brain cannabinoid binding sites after chronic 8 -tetrahydrocannabinol treatment.Pharmacol. Biochem. Behav.,47, 33–40.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez de Fonseca, F.A., Martin-Calderon, J.L., Del Arco, I., Gorriti, M.A., Navarro, M. (1998) Role of the endogenous cannabinoid system in the regulation of motor activity.Neurobiology of Disease 5, 483–501.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez de Fonseca F, Martin-Calderon JL, Mechoulam R and Navarro M (1994b) Repeated stimulation of D-l dopamine receptors enhances (-)-ll-hydroxy-Δ8-tetrahydrocannabinol-dimethylheptyl-induced catalepsy in male rats.NeuroReport,5, 761–765.

    PubMed  CAS  Google Scholar 

  • Rodriguez de Fonseca, F., Wenger, T., Navarro, M.; Murphy, L.L. (1999) Effects of THC on VIP-induced prolactin secretion in pituitary cultures: evidence for the presence of functional cannabinoid receptors in pituitary cells.Brain Res. 841, 114–122.

    Article  PubMed  CAS  Google Scholar 

  • Romero J, Garcfa-Palomero E, Fernandez-Ruiz JJ and Ramos JA (1995) Involvement of GABA-B receptors in the motor inhibition produced by agonists of brain cannabinoid receptors.Behav. Pharmacol.,7, 299–302.

    Article  Google Scholar 

  • Sanudo-Pena MC, Patrick SL, Patrick RL and Walker JM (1996) Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.Neurosci. Lett,206, 21–24.

    Article  PubMed  CAS  Google Scholar 

  • Sanudo-Pena MC and Walker JM (1997) Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat.J. Neurophysiol,77, 1635–1638.

    PubMed  CAS  Google Scholar 

  • Sanudo-Pena, M.C. and Walker, J.M. (1998). Effects of intrapallidal cannabinoids on rotational behavior in rats. Interaction with the dopaminergic system. Synapse28, 2–32.

    Google Scholar 

  • Sim, L.J., Selley, D.E., Dworkin, S.I. and Childers, S.R. (1996) Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgS autoradiography in rat brain. J. Neurosci.,16, 2684–2692.

    PubMed  CAS  Google Scholar 

  • Steiner, H., Bonner, T.I., Zimmer, A.M., Kitai, S.T. and Zimmer, A. (1999) Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice.Proc. Natl. Acad. Sci. 96, 5786–5790.

    Article  PubMed  CAS  Google Scholar 

  • Stella N, Schweitzer P and Pomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation.Nature,388, 773–777.

    Article  PubMed  CAS  Google Scholar 

  • Surmeier DJ, Song WJ and Yan Z (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons.J. Neurosci.,16, 6579–6591.

    PubMed  CAS  Google Scholar 

  • Tanda, G, Pontieri, FE, Di Chiara, G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mul opioid receptor mechanism.Science 76, 2048–2050.

    Article  Google Scholar 

  • Tersigni T and Rosemberg HC (1996) Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA.Brain Res.,733, 184–192.

    Article  PubMed  CAS  Google Scholar 

  • Tsou, K., Sanudo-Pena, M.C, Mackie, K., Walker, J.M. (1998) Immunohystochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.Neuroscience 83, 393–411.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Psicobiología, Facultad de Psicología, Universidad Complutense de Madrid, Campus de Somosaguas, 28223, Madrid, Spain

    Fernando Rodríguez de Fonseca, Miguel A. Gorriti, Ainhoa Bilbao, Leticia Escuredo & Miguel Navarro

  2. Institute Cajal, Consejo Superior de Investigaciones Cientificas, Madrid, Spain

    Luis Miguel García-segura

  3. Department of Pharmacology, University of California at Irvine, USA

    Daniele Piomelli

Authors
  1. Fernando Rodríguez de Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miguel A. Gorriti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ainhoa Bilbao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leticia Escuredo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luis Miguel García-segura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daniele Piomelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Miguel Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fernando Rodríguez de Fonseca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fonseca, F.R.d., Gorriti, M.A., Bilbao, A. et al. Role of the endogenous cannabinoid system as a modulator of dopamine transmission: Implications for Parkinson’s disease and schizophrenia. neurotox res 3, 23–35 (2001). https://doi.org/10.1007/BF03033228

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033228

Keywords

Search

Navigation